167 related articles for article (PubMed ID: 30582730)
1. Co-existence of mycobacterial infections: is it an emerging issue with retroviral infections?
Keragala B; Herath H; Janappriya G; Gunasekera CN
Trop Doct; 2019 Apr; 49(2):145-146. PubMed ID: 30582730
[TBL] [Abstract][Full Text] [Related]
2. Variations in leprosy manifestations among HIV-positive patients, Manaus, Brazil.
Talhari C; Matsuo C; Chrusciak-Talhari A; de-Lima-Ferreira LC; Mira M; Talhari S
Emerg Infect Dis; 2009 Apr; 15(4):673-4. PubMed ID: 19331771
[No Abstract] [Full Text] [Related]
3. A case of histoid leprosy in a HIV infected person on HAART not responding to conventional MB-MDT.
Kolaparambath BA; Rajagopal R
Indian J Lepr; 2014; 86(1):15-8. PubMed ID: 25163256
[TBL] [Abstract][Full Text] [Related]
4. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
Krenzien HN
Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
[No Abstract] [Full Text] [Related]
5. Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons.
Martiniuk F; Rao SD; Rea TH; Glickman MS; Giovinazzo J; Rom WN; Cabrera A; Levis WR
Emerg Infect Dis; 2007 Sep; 13(9):1438-40. PubMed ID: 18252138
[No Abstract] [Full Text] [Related]
6. An unusual reaction to rifampicin in a once monthly dose.
Sule RR
Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
[No Abstract] [Full Text] [Related]
7. The treatment of tuberculosis and leprosy.
Ellard GA
Lepr Rev; 1975 Sep; 46(3):149-55. PubMed ID: 1102829
[No Abstract] [Full Text] [Related]
8. Do complications occur under multi-drug therapy?
Palande DD
Indian J Lepr; 1987; 59(4):369-72. PubMed ID: 3451922
[No Abstract] [Full Text] [Related]
9. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
Mieras L; Anthony R; van Brakel W; Bratschi MW; van den Broek J; Cambau E; Cavaliero A; Kasang C; Perera G; Reichman L; Richardus JH; Saunderson P; Steinmann P; Yew WW
Infect Dis Poverty; 2016 Jun; 5(1):46. PubMed ID: 27268059
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin and isoprodian in combination in the treatment of leprosy.
Depasquale G
Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
[No Abstract] [Full Text] [Related]
11. A Case of Histoid Leprosy in a HIV Infected Person on HAART not responding to conventional MB MDT.
Kolaparambath BA; Rajagopal R
Indian J Lepr; 2014; 86(4):165-9. PubMed ID: 26411250
[TBL] [Abstract][Full Text] [Related]
12. Leprosy and HIV coinfection: a critical approach.
Massone C; Talhari C; Ribeiro-Rodrigues R; Sindeaux RH; Mira MT; Talhari S; Naafs B
Expert Rev Anti Infect Ther; 2011 Jun; 9(6):701-10. PubMed ID: 21692674
[TBL] [Abstract][Full Text] [Related]
13. Leprosy and HIV co-infection in five patients.
Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of mycobacterial infections - Mycobacterium tuberculosis and Mycobacterium leprae - in Sri Lanka: a case series.
Keragala BSDP; Herath HMMTB; Janapriya GHDC; Vanitha S; Balendran T; Janani T; Keragala TS; Gunasekera CN
J Med Case Rep; 2020 Jul; 14(1):101. PubMed ID: 32669124
[TBL] [Abstract][Full Text] [Related]
15. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
Aschhoff M
Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
[No Abstract] [Full Text] [Related]
16. Informal consultation on rifampicin resistance in leprosy.
Lepr Rev; 2007 Sep; 78(3):295-305. PubMed ID: 18035782
[No Abstract] [Full Text] [Related]
17. Secondary rifampin resistance following multi-drug therapy--a case report.
Norman G; Joseph G; Ebenezer G; Rao SP; Job CK
Int J Lepr Other Mycobact Dis; 2003 Mar; 71(1):18-21. PubMed ID: 12914130
[TBL] [Abstract][Full Text] [Related]
18. Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
Trindade MÂ; Miyamoto D; Benard G; Sakai-Valente NY; Vasconcelos Dde M; Naafs B
Am J Trop Med Hyg; 2013 Feb; 88(2):236-40. PubMed ID: 23208884
[TBL] [Abstract][Full Text] [Related]
19. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Chum HJ
Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
[No Abstract] [Full Text] [Related]
20. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Depasquale G
Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
